Alan Boobis studied pharmacology at the University of Glasgow and obtained a PhD in 1974. Following a Fogarty fellowship at the NIH, Bethesda, USA, he returned to the UK in 1976 to join the Department of Clinical Pharmacology, Royal Postgraduate Medical School (RPMS) in London as an MRC post-doctoral fellow. In 1979 he was appointed as a lecturer, and was promoted to professor in 1996, his current position. In 1997, the RPMS merged with Imperial College London. He is also currently Director of the Public Health England Toxicology Unit, based in Imperial College London. His main research interests lie in mechanistic toxicology, drug metabolism, toxicity pathway analysis and increasingly over the last 20 years or so, in the application of knowledge in these areas to risk assessment. He has published around 230 original research papers (H-factor ~60). He is or has been a member of a number of national and international advisory committees and scientific advisory boards. He has served as president of Eurotox and received the Merit Award in 2009. He is a past chair of the British Toxicology Society and received the John Barnes Prize Lectureship in 2013. He was recipient of the Royal Society of Chemistry Toxicology Award in 2013. He received an OBE in 2003 for his work on risk assessment.